Wen H. Shen

Dr. Wen H. Shen


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Cell
Verified
Journal Article
Closed access
WSWen H. Shen
Wen H. Shen
ABAdayabalam S. Balajee
Adayabalam S. Balajee
JWJianli Wang
Jianli Wang
HWHong Wu
Hong Wu
CECharis Eng
Charis Eng
YYYuxin Yin
Yuxin Yin

1 February 2003 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
Keith W KelleyKeith W Kelley
Keith W Kelley
RBRose-Marie Bluthé
Rose-Marie Bluthé
RDRobert Dantzer
Robert Dantzer
JZJian-Hua Zhou
Jian-Hua Zhou
WSWen H. Shen
Wen H. Shen
SBSuzanne R. Broussard
Suzanne R. Broussard

15 September 2008 in Oncogene
Verified
Journal Article
Open access
PDF file
YYY Yin
Y Yin
WSWen H. Shen
Wen H. Shen
The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor is a phosphatase that antagonizes the phosphoinositol-3-kinase/AKT signaling pathway and suppresses cell survival as well as cell proliferation. PTEN is the second most frequently mutated gene in human cancer after p53. Germline mutations of PTEN have been found in cancer susceptibility syndromes, such as Cowden syndrome, in which over 80% of patients have mutations of PTEN. Homozygous deletion of Pten causes embryonic lethality, suggesting that PTEN is essential for embryonic development. Mice heterozygous for Pten develop spontaneous tumors in a variety of organs comparable with the spectrum of its mutations in human cancer. The mechanisms of PTEN functions in tumor suppression are currently under intense investigation. Recent studies demonstrate that PTEN plays an essential role in the maintenance of chromosomal stability and that loss of PTEN leads to massive alterations of chromosomes. The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death. Through completely different mechanisms, PTEN also protects the genome from instability. Thus, we propose that PTEN is a new guardian of the genome. In this review, we will discuss new discoveries on the role of PTEN in tumor suppression and explore mechanisms by which PTEN maintains genomic stability.

1 May 2014 in Cell Metabolism
Verified
Journal Article
Closed access
HLHui Liang
Hui Liang
SHShiming He
Shiming He
JYJingyi Yang
Jingyi Yang
XJXinying Jia
Xinying Jia
PWPan Wang
Pan Wang
YYYuxin Yin
Yuxin Yin

13 April 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
TGTingting Gu
Tingting Gu
ZZZhong Zhang
Zhong Zhang
JWJianli Wang
Jianli Wang
JGJunyi Guo
Junyi Guo
WSWen H. Shen
Wen H. Shen
YYYuxin Yin
Yuxin Yin
PTEN phosphatase is a potent tumor suppressor that regulates multiple cellular functions. In the cytoplasm, PTEN dephosphorylates its primary lipid substrate, phosphatidylinositol 3,4,5-trisphosphate, to antagonize the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. It has also become increasingly evident that PTEN functions in the nucleus and may play an important part in transcription regulation, but its nuclear targets remain elusive. In this report, we demonstrate the transcription factor cyclic AMP response element-binding protein (CREB) is a protein target of PTEN phosphatase and that PTEN deficiency leads to CREB phosphorylation independent of the PI3K/AKT pathway. Using confocal immunofluorescence and reciprocal immunoprecipitation, we further show that PTEN colocalizes with CREB and physically interacts with CREB. Moreover, we use both in vitro and in vivo experiments to show PTEN can dephosphorylate CREB in a phosphatase-dependent manner, suggesting that CREB is a substrate of PTEN nuclear phosphatase. Loss of Pten results in an elevated RNA level of multiple CREB transcriptional targets and increased cell proliferation, which can be reversed by a nonphosphorylatable CREB mutant or knockdown of CREB. These data reveal a mechanism for PTEN modulation of CREB-mediated gene transcription and cell growth. Our study thus characterizes PTEN as a nuclear phophatase of a transcription factor and identifies CREB as a novel protein target of PTEN phosphatase, which contributes to better understanding of PTEN function in the nucleus. Cancer Res; 71(8); 2821–5. ©2011 AACR.

1 September 2014 in Cell Reports
Verified
Journal Article
Open access
ZCZhu Hong Chen
Zhu Hong Chen
MZMinglu Zhu
Minglu Zhu
JYJingyi Yang
Jingyi Yang
HLHui Liang
Hui Liang
JHJinxue He
Jinxue He
WSWen H. Shen
Wen H. Shen
Chromatin organization and dynamics are integral to global gene transcription. Histone modification influences chromatin status and gene expression. PTEN plays multiple roles in tumor suppression, development, and metabolism. Here, we report on the interplay of PTEN, histone H1, and chromatin. We show that loss of PTEN leads to dissociation of histone H1 from chromatin and decondensation of chromatin. PTEN deletion also results in elevation of histone H4 acetylation at lysine 16, an epigenetic marker for chromatin activation. We found that PTEN and histone H1 physically interact through their C-terminal domains. Disruption of the PTEN C terminus promotes the chromatin association of MOF acetyltransferase and induces H4K16 acetylation. Hyperacetylation of H4K16 impairs the association of PTEN with histone H1, which constitutes regulatory feedback that may reduce chromatin stability. Our results demonstrate that PTEN controls chromatin condensation, thus influencing gene expression. We propose that PTEN regulates global gene transcription profiling through histones and chromatin remodeling.